New scan could replace invasive biopsies for cancer treatment decisions
NCT ID NCT05742269
Summary
This study tested a new type of PET scan to see if it could better predict which patients with advanced triple-negative breast cancer would benefit from immunotherapy. The scan uses a radioactive tracer to detect a specific protein (PD-L1) throughout the body, aiming to be more accurate than a standard biopsy. The goal was to help doctors choose the right treatment for each patient by getting a clearer, whole-body picture of the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Karolinska University Hospital
Stockholm, 171 76, Sweden
Conditions
Explore the condition pages connected to this study.